IMMB - In Harry Zhabilov’s paper, Immune Therapeutic Vaccine (ITV): A Fusion Inhibitor and Immunomodulator, our Chief Science Officer details his motivation for exploring this therapeutic avenue,
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.